title: Legionella jordanis lower respiratory tract infection: case report and review.
abstract: Legionella jordanis was first described in 1982 after isolation from environmental sources and is otherwise a very rare human pathogen. Here, we report the recovery of L. jordanis from a bronchoalveolar lavage specimen from a patient who presented with an indolent lower respiratory tract infection associated with constitutional symptoms. This case is the first culture-positive case of infection involving this species in Canada.
authors.affiliation: Department of Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada.
authors.forename: Donald C
authors.initials: DC
authors.lastname: Vinh
authors.forename: Richard
authors.initials: R
authors.lastname: Garceau
authors.forename: Gabriela
authors.initials: G
authors.lastname: Martinez
authors.forename: Debbie
authors.initials: D
authors.lastname: Wiebe
authors.forename: Tamara
authors.initials: T
authors.lastname: Burdz
authors.forename: Aleisha
authors.initials: A
authors.lastname: Reimer
authors.forename: Kathryn
authors.initials: K
authors.lastname: Bernard
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D024841:Fluoroquinolones; D006801:Humans; D007875:Legionella / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D007876:Legionellosis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin